3M Collaborates with MIT to Develop Paper-Based Diagnostic Test for COVID-19

 3M Collaborates with MIT to Develop Paper-Based Diagnostic Test for COVID-19

Shots:

  • 3M is working with MIT’s researcher to develop a rapid COVID-19 diagnostic using a simple, paper-based test that detects viral antigens and produces accurate results within minutes and is feasible to mass manufacture
  • The collaboration leverages 3M’s expertise in biomaterials and bioprocessing along with the global medical device manufacturing capabilities. 3M and MIT believe a diagnostic test can be deployed once validated and expect to produce millions of units/ day
  • NIH has supported the project under competitive Rapid Acceleration of Diagnostics Tech (RADx Tech) program launched in early May to combat COVID-19. The project received $500,000 for validation funding from RADx Tech and is eligible for further investment in later stages of the development

Click here to­ read full press release/ article | Ref: Businesswire | Image: Businesswire

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post